Zyla Life Sciences Notes and Loans, Noncurrent
Zyla Life Sciences had Notes and Loans, Noncurrent of $91.35 million as of 2020-03-31, per its 10-Q filed 2020-05-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities
us-gaap:LongTermNotesAndLoans · last filed 2020-05-14
- 2020-03-31: Notes and Loans, Noncurrent $91.35M.
- 2019-12-31: Notes and Loans, Noncurrent $91.71M.
- 2019-09-30: Notes and Loans, Noncurrent $92.63M.
- 2019-06-30: Notes and Loans, Noncurrent $93.25M.
| Period end | Notes and Loans, Noncurrent |
|---|---|
| 2020-03-31 | $91.35M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $91.71M 10-Q · filed 2020-05-14 |
| 2019-09-30 | $92.63M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $93.25M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $92.96M 10-Q · filed 2019-05-17 |
| 2019-02-01 | $93.37M 10-Q · filed 2020-05-14 |
| 2019-01-31 | $93.37M 10-Q · filed 2019-08-13 |